The Australian: Regulator moves to require SSRI antidepressants to carry product warnings on the risk of long-lasting sexual side effects.
The article “Regulator Moves To Require SSRI Antidepressants To Carry Product Warnings On The Risk Of Long-Lasting Sexual Side Effects” by Natasha Robinson covers the added warnings in Australia regarding persistent sexual dysfunction for all SSRIs and SNRIs. The updated warning encourages health professionals to be alert to the issue and to report cases they associate antidepressant use with sexual dysfunction. Reporting adverse side effects can lead to increase warnings and labeling and are essential for raising interest in the issue. To report your adverse effects, please find your health agency here.